T15	Exp 119 123	that
T16	Exp 88 118	The transcriptional mechanisms
T17	Exp 304 306	We
T18	Exp 318 322	that
T19	Exp 431 435	that
T20	Exp 323 332	the c-Maf
T21	Exp 601 623	the promyelocyte stage
T22	Exp 672 685	the induction
T23	Exp 528 543	These complexes
T24	Exp 716 718	We
T25	Exp 742 782	this developmentally related interaction
T26	Exp 1006 1008	we
T27	Exp 877 893	the elevated Myb
T28	Exp 1029 1043	the c-Maf cDNA
T29	Exp 1172 1188	the accumulation
T30	Exp 1283 1287	that
T31	Exp 1337 1341	that
T32	Exp 1521 1535	the activation
T33	Exp 1302 1326	these phenotypic changes
R4	Coref Anaphora:T15 Antecedent:T16
R5	Coref Anaphora:T19 Antecedent:T34
R6	Coref Anaphora:T30 Antecedent:T35
T1	Protein 0 5	c-Maf
T2	Protein 327 332	c-Maf
T3	Protein 337 342	c-Myb
T4	Protein 462 467	c-Myb
T5	Protein 977 982	c-Maf
T6	Protein 1033 1038	c-Maf
T7	Protein 1109 1114	c-Maf
T8	Protein 1342 1347	c-Maf
T9	Protein 1455 1460	c-Myb
T10	Protein 1488 1493	Bcl-2
T11	Protein 1498 1502	CD13
T12	Protein 1503 1506	APN
T34	Exp 410 430	inhibitory complexes
T35	Exp 1275 1282	targets
